Axogen

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Axogen and other ETFs, options, and stocks.

About AXGN

Axogen, Inc. engages in the development and market of surgical solutions for peripheral nerve regeneration and repair. It also provides products and education to improve surgical treatment algorithms for peripheral nerve damage or discontinuity. 

CEO
Michael D. Dale
CEOMichael D. Dale
Employees
622
Employees622
Headquarters
Alachua, Florida
HeadquartersAlachua, Florida
Founded
1977
Founded1977
Employees
622
Employees622

AXGN Key Statistics

Market cap
2.17B
Market cap2.17B
Price-Earnings ratio
-65.95
Price-Earnings ratio-65.95
Dividend yield
Dividend yield
Average volume
1.64M
Average volume1.64M
High today
$42.11
High today$42.11
Low today
$40.34
Low today$40.34
Open price
$41.52
Open price$41.52
Volume
1.22M
Volume1.22M
52 Week high
$45.83
52 Week high$45.83
52 Week low
$9.22
52 Week low$9.22

Stock Snapshot

With a market cap of 2.17B, Axogen(AXGN) trades at $41.81. The stock has a price-to-earnings ratio of -65.95.

On 2026-04-30, Axogen(AXGN) stock traded between a low of $40.34 and a high of $42.11. Shares are currently priced at $41.81, which is +3.6% above the low and -0.7% below the high.

Axogen(AXGN) shares are trading with a volume of 1.22M, against a daily average of 1.64M.

In the last year, Axogen(AXGN) shares hit a 52-week high of $45.83 and a 52-week low of $9.22.

In the last year, Axogen(AXGN) shares hit a 52-week high of $45.83 and a 52-week low of $9.22.

AXGN News

TipRanks 14h
AxoGen price target raised to $48 from $41 at Raymond James

Raymond James raised the firm’s price target on AxoGen (AXGN) to $48 from $41 and keeps an Outperform rating on the shares. Axogen is delivering its strongest g...

Nasdaq 1d
Axogen Q3 2025 Earnings Transcript

AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX ADP SBUX MRNA AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX AD...

Axogen Q3 2025 Earnings Transcript
Nasdaq 2d
AxoGen Q1 Earnings Lag Estimates

AxoGen (AXGN) came out with quarterly earnings of $0.07 per share, missing the Zacks Consensus Estimate of $0.12 per share. This compares to a loss of $0.02 per...

AxoGen Q1 Earnings Lag Estimates

Analyst ratings

100%

of 10 ratings
Buy
100%
Hold
0%
Sell
0%

More AXGN News

TipRanks 2d
AxoGen Delivers Strong Q1 Growth and Raises 2026 Outlook

Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...

Simply Wall St 6d
Is Axogen’s Upgraded Outlook And Avance BLA Progress Altering The Investment Case For Axogen?

Axogen recently reported strong second-quarter 2025 results, highlighting double-digit sales growth across its nerve repair markets and reaffirming progress tow...

Is Axogen’s Upgraded Outlook And Avance BLA Progress Altering The Investment Case For Axogen?

People also own

Based on the portfolios of people who own AXGN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.